omni
accorg
FDA Approves Lixisenatide For Type-2 Diabetes Patients - See more at: http://www.acc.org/latest-i...
FDA Approves Lixisenatide For Type-2 Diabetes Patients - See more at: http://www.acc.org/latest-i...
The U.S. Food and Drug Administration (FDA) on July 28 approved Sanofi�s Adlyxin (lixisenatide) to improve glycemic control in patients with type 2 diabetes. The drug is a glucagon-like peptide-1 receptor agonist and is administered once daily via inje...
Stroke Center Hospitalization for Elderly Stroke Patients - See more at: http://www.acc.org/lates...
Stroke Center Hospitalization for Elderly Stroke Patients - See more at: http://www.acc.org/lates...
This study reports that hospitalization of patients with stroke in PSCs was associated with decreased 7-day and 30-day case fatality compared with noncertified hospitals. Traveling at least 90 minutes to receive care offset the 30-day survival benefit ...
Recommendations From the NHLBI�s Health Inequities Think�Tank Meeting
Recommendations From the NHLBI�s Health Inequities Think�Tank Meeting
The National, Heart, Lung, and Blood Institute convened a Think Tank meeting to obtain insight and recommendations regarding the objectives and design of the next generation of research aimed at reducing health inequities in the United States.
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset He...
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset He...
Although ischemic coronary artery disease (CAD) is the most common etiology of heart failure (HF), the extent to which patients with new-onset HF actually undergo an ischemic work-up and/or revascularization is not well defined.